Sixty Degree Capital focuses its investments on technology (AI, cybersecurity, digital infrastructure, SaaS) and healthcare (drug development, diagnostics, digital health, medical devices), investing from pre-seed to growth stages. Their strategy is thesis-driven, combining deep technical expertise, rigorous analysis, and operational support to back breakthrough opportunities.
Portfolio
1
Fund Size
—
Top Stage
Series B
Last 12 Mo
1
Stage Distribution
Portfolio
1 investment
| Company | Round | Amount | Date |
|---|---|---|---|
| AAVantgarde Bio | Series B | $141M | Nov 2025 |
Top Co-Investors
Atlas Venture1 shared
Forbion1 shared
Schroders Capital1 shared
ATHOS1 shared
CDP Venture Capital1 shared
NEVA SGR1 shared
Willett Advisors1 shared
Last updated: 3 March 2026